Literature DB >> 18023188

Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH).

Craig E Wheelock1, Kosuke Nishi, Andy Ying, Paul D Jones, Michael E Colvin, Marilyn M Olmstead, Bruce D Hammock.   

Abstract

Carboxylesterases metabolize numerous exogenous and endogenous ester-containing compounds including the chemotherapeutic agent CPT-11, anti-influenza viral agent oseltamivir, and many agrochemicals. Trifluoromethyl ketone (TFK)-containing compounds with a sulfur atom beta to the ketone moiety are some of the most potent carboxylesterase and amidase inhibitors identified to date. This study examined the effects of alkyl chain length (i.e., steric effects) and sulfur oxidation state upon TFK inhibitor potency (IC50) and binding kinetics (k(i)). The selective carboxylesterase inhibitor benzil was used as a non-TFK containing control. These effects were examined using two commercial esterases (porcine and rabbit liver esterase) and two human recombinant esterases (hCE-1 and hCE-2) as well as human recombinant fatty acid amide hydrolase (FAAH). In addition, the inhibition mechanism was examined using a combination of 1H NMR, X-ray crystallography, and ab initio calculations. Overall, the data show that while sulfur oxidation state profoundly affects both inhibitor potency and binding kinetics, the steric effects dominate and override the contributions of sulfur oxidation. In addition, the data suggest that inclusion of a sulfur atom beta to the ketone contributes an increase (approximately 5-fold) in inhibitor potency due to effects upon ketone hydration and/or intramolecular hydrogen bond formation. These results provide further information on the nature of the TFK binding interaction and will be useful in increasing our understanding of this basic biochemical process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023188      PMCID: PMC2720161          DOI: 10.1016/j.bmc.2007.10.081

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  42 in total

Review 1.  Soft drug design: general principles and recent applications.

Authors:  N Bodor; P Buchwald
Journal:  Med Res Rev       Date:  2000-01       Impact factor: 12.944

2.  Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Authors:  Christopher D Fleming; Sompop Bencharit; Carol C Edwards; Janice L Hyatt; Lyudmila Tsurkan; Feng Bai; Charles Fraga; Christopher L Morton; Escher L Howard-Williams; Philip M Potter; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

3.  Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.

Authors:  Randy M Wadkins; Janice L Hyatt; Xin Wei; Kyoung Jin P Yoon; Monika Wierdl; Carol C Edwards; Christopher L Morton; John C Obenauer; Komath Damodaran; Paul Beroza; Mary K Danks; Philip M Potter
Journal:  J Med Chem       Date:  2005-04-21       Impact factor: 7.446

4.  Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.

Authors:  K Brady; A Z Wei; D Ringe; R H Abeles
Journal:  Biochemistry       Date:  1990-08-21       Impact factor: 3.162

5.  Structural insights into CPT-11 activation by mammalian carboxylesterases.

Authors:  Sompop Bencharit; Christopher L Morton; Escher L Howard-Williams; Mary K Danks; Philip M Potter; Matthew R Redinbo
Journal:  Nat Struct Biol       Date:  2002-05

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

Review 7.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.

Authors:  Benjamin F Cravatt; Aron H Lichtman
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone.

Authors:  R A Smith; L J Copp; S L Donnelly; R W Spencer; A Krantz
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

9.  Investigation of the role of a second conserved serine in carboxylesterases via site-directed mutagenesis.

Authors:  Jeanette E Stok; Andrey Goloshchapov; Cheng Song; Craig E Wheelock; Maher B H Derbel; Christophe Morisseau; Bruce D Hammock
Journal:  Arch Biochem Biophys       Date:  2004-10-15       Impact factor: 4.013

10.  Chemical characterization of a family of brain lipids that induce sleep.

Authors:  B F Cravatt; O Prospero-Garcia; G Siuzdak; N B Gilula; S J Henriksen; D L Boger; R A Lerner
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

View more
  4 in total

1.  Reactivity versus steric effects in fluorinated ketones as esterase inhibitors: a quantum mechanical and molecular dynamics study.

Authors:  Josep Rayo; Lourdes Muñoz; Gloria Rosell; Bruce D Hammock; Angel Guerrero; F Javier Luque; Ramon Pouplana
Journal:  J Mol Model       Date:  2010-07-31       Impact factor: 1.810

2.  Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.

Authors:  Sean D Kodani; Saavan Bhakta; Sung Hee Hwang; Svetlana Pakhomova; Marcia E Newcomer; Christophe Morisseau; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2018-01-04       Impact factor: 2.823

3.  Juvenile hormone esterase: biochemistry and structure.

Authors:  Shizuo G Kamita; Bruce D Hammock
Journal:  J Pestic Sci       Date:  2010-06-18       Impact factor: 1.519

4.  Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.

Authors:  Toshiyuki Harada; Yoshiaki Nakagawa; Randy M Wadkins; Philip M Potter; Craig E Wheelock
Journal:  Bioorg Med Chem       Date:  2008-11-09       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.